Clincosm LogoSign in Get a demo

Gastrointestinal Stromal Tumors

Showing NaN - NaN of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Rivoceranib Mesylate, Paclitaxel
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jun 7, 2023

Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 30, 2022

Gastrointestinal Stromal Tumors Trial (Imatinib Mesylate)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Imatinib Mesylate
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Dec 22, 2022

Gastrointestinal Stromal Tumors Trial in Seoul (Temozolomide capsule)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Temozolomide capsule
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Dec 14, 2022

Gastrointestinal Stromal Tumors Trial in Seoul (PDR001, Imatinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • PDR001, Imatinib
  • Seoul, Korea, Republic of
    Asan Medical Center
Jun 22, 2021

Gastrointestinal Stromal Tumors Trial in Seoul (imatinib)

Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jun 22, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506), Placebo, Best supportive care)

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Regorafenib (Stivarga, BAY73-4506)
  • +2 more
  • Scottsdale, Arizona
  • +56 more
Jan 27, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Sunitinib)

Unknown status
  • Gastrointestinal Stromal Tumors
  • Scottsdale, Arizona
  • +120 more
Jan 4, 2021

Gastrointestinal Stromal Tumors Trial in Seoul (Imatinib, Placebo)

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jan 6, 2020

Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)

Completed
  • Gastrointestinal Stromal Tumors
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020

Sarcoma, Gastrointestinal Stromal Tumors Trial in Goyang, Seoul (Imatinib mesylate (Glivec))

Completed
Has Results
  • Sarcoma
  • Gastrointestinal Stromal Tumors
  • Imatinib mesylate (Glivec)
  • Goyang, Korea, Republic of
  • +3 more
Jan 6, 2020

(PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK

Completed
  • Gastrointestinal Stromal Tumors
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 6, 2020

Observe Safety And Efficacy Of Sutene

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Sunitinib malate
  • sunitinib malate
  • Jung-gu, Daegu, Korea, Republic of
  • +46 more
Dec 6, 2016

Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Imatinib)

Terminated
Has Results
  • Gastrointestinal Stromal Tumors
  • Caba, Buenos Aires, Argentina
  • +31 more
Feb 25, 2014

Malnourished, Stomach Tumors, Gastrointestinal Stromal Tumors Trial in Seoul (Ensure powder)

Completed
  • Malnourished
  • +2 more
  • Ensure powder
  • Seoul, Korea, Republic of
    Department of Surgery, Seoul National University Hospital
Mar 12, 2014

Chronic Myeloid Leukemia, Gastrointestinal Stromal Tumors Trial in Seoul (Luckyvec 400mg film coated tablet, Glivec 100mg film

Completed
  • Chronic Myeloid Leukemia
  • Gastrointestinal Stromal Tumors
  • Luckyvec 400mg film coated tablet
  • Glivec 100mg film coated tablet
  • Seoul, Korea, Republic of
    The Korea University Anam Hospital
Oct 30, 2012

Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Best Supportive Care (BSC) +/- imatinib or sunitinib)

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Nilotinib
  • Best Supportive Care (BSC) +/- imatinib or sunitinib
  • Los Angeles, California
  • +34 more
Jun 5, 2012

Gastrointestinal Stromal Tumors Trial in Seoul (Sorafenib)

Completed
  • Gastrointestinal Stromal Tumors
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 18, 2012